Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 5,626 shares at $27.76 ($156K) on 2024-07-24, disclosed to the SEC on 2024-07-26.
Open-market sale of $156k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.76 | 2,813 | $78K | 50.0% |
| 2 | $27.76 | 2,813 | $78K | 50.0% |
| Total | $27.76 avg | 5,626 | $156K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |